patients had heart valve replacement with frame-mounted autologous or homologous fascia lata or with heterologous pericardial grafts. There were 111 single aortic, 95 single mitral, and seven tricuspid valve replacements.
Thirty-three patients in this series had multiple valve replacement, single tricuspid valve replacement, or unmounted grafts inserted in the aortic position. This report will analyse those patients who had isolated aortic or mitral valve replacement and will briefly present the results of a small group of patients who had tricuspid valve replacement. In the single aortic valve replacement group there were 111 patients aged 13 to 69 years. Seventy-eight were males and 33 females. In the single mitral valve replacement group there were 95 patients aged 9 to 68 years. Forty-two were males and 53 females. Seven patients (4 men and 3 women) aged 29 to 48 years had tricuspid valve replacement either alone or in combination with other cardiac surgical procedures.
Details of preoperative heart valve lesions are given in Table I . At the time of heart valve replacement the majority of patients were in grade II and III, assessed according to the New York Heart Association (NYHA) classification. 56 (lonescu et al., 1970b; Ionescu et al., 1972; Bartek, Holden, and Ionescu, 1974) . Valves prepared from the patient's own fascia lata at the time of surgery, under sterile conditions, were used in 80 cases (25 in the aortic, 52 in the mitral, and 3 in the tricuspid position). Preserved homologous fascia lata was used in 65 patients (44 in the aortic, 20 in the mitral, and one in the tricuspid position). Sixty-eight patients (42 with aortic, 23 with mitral, and 3 with tricuspid replacement) had valves made of preserved heterologous pericardium2.
The homologous fascia lata valves were sterilized and preserved in either 0-2% buffered glutaraldehyde (Reis et al., 1971) or 4% buffered formaldehyde (Moeys, Mreyen, and den Hartog, 1954) . The heterologous pericardial valves were either treated with 2Catf pericardium was used throughout this series.
0-2% buffered glutaraldehyde or given the complex chemical treatment described by Carpentier and Dubost (1972) . These valves were used during successive periods of time, as shown in Table II (Table III) . There have not been early or late deaths in patients with tricuspid valve replacement.
Actuarial representation of survival among 103 patients with aortic and 80 patients with mitral replacement who were discharged from hospital and followed for a period of up to four and a half years is shown in Figure 1 .
Infective endocarditis occurred in both the aortic and the mitral series, and the incidence was similar. Contamination during the surgical period 9 (1) . . . (Table IV) . Infective endocarditis has not been diagnosed in the tricuspid replacement series. An analysis of the occurrence of infective endocarditis over the years showed that the infection rate has considerably decreased over the last three years (Table V) since a rigorous system of microbiological monitoring was introduced together with a reduction in the duration of the prophylactic antibiotic therapy (Freeman, 1974; Freeman and King, 1972a and b) . Brandt, Roche, BarrattBoyes, and Lowe (1969) (Fig. 2) . Although the number of patients with postoperative aortic regurgitation is too small for correct statistical analysis, a higher incidence of aortic regurgitation (Table VI) .
Mitral systolic murmurs developed in 51-6% of patients ( Fig. 2) . In all cases except one, the murmur appeared during the first 12 months postoperatively. Eight patients with murmurs had their grafts removed because of graft failure in six and graft dysfunction in two. In the remaining 33 cases with mitral systolic murmurs, the murmur has not increased in intensity in 24 patients while in nine it has gradually progressed. Angiographic studies in some of these patients have shown that not every systolic murmur is associated with mitral valve graft regurgitation.
On clinical criteria, all tissue valves in the tricuspid position are competent.
Graft failure and dysfunction There has not been any instance of valve graft failure in either the aortic or the tricuspid position. Two grafts have been removed from the aortic area, one eight months after implantation of a defectively prepared valve and the second one 37 months postoperatively. This second case developed infective endocarditis in the immediate postoperative period (Table VII) . Mitral systolic murmurs were heard in these cases in the first six postoperative months. The grafts were removed 10 to 38 months after implantation. All six patients survived reoperation and prosthetic mitral valve replacement. One of them died two years after reoperation following oesophagectomy.
All six grafts which were originally made of autologous fascia lata showed retraction and severe thickening of one cusp and slight to moderate thickening of the other cusps of the graft (Figs. 3a and b) . There was no relationship between the severely retracted cusp and the circumferential position of that cusp as regards the left ventricular outlet (Fig. 4) .
Two grafts with mechanical dysfunction due to faulty valve preparation were removed from the mitral position. One of them, which was removed six months after insertion, had a trivial central leak, while the second one removed 18 months postoperatively had acute disruption of a suture line and one cusp had become detached from the frame. Both these valves appeared macroscopically to be identical with freshly prepared valves. The cusps were thin and pliable and they retained the normal fascial striae. Both patients are well after reoperation and prosthetic valve replacement.
All the failed grafts removed from patients were fixed, sectioned, stained, and examined microscopically. The failed grafts examined showed a central, slightly fragmented band of necroticlooking connective tissue and a superficial narrow band of fibrous tissue along the surface of the central band. In the less retracted cusps the superficial band appeared viable and its fibres were thickened and hyaline. The thickening of the cusps can be accounted for by the formation of a thick hyaline fibrous sheath (Fig. 5 ). This sheath corresponds to the pseudo-intima described by Silver and Trimble (1972) . It was clearly continuous with the host connective tissue, but whether organization has proceeded from the periphery or from the blood stream could not be determined from these sections. Advanced preoperative heart disease and infective endocardi,tis were the main causes of late deaths in this series.
Since January 1971, the policy of preventing, detecting, and treating infections has been completely changed. The patients receive 1 g of ampicillin-cloxacillin six-hourly for 48 hours only, during and after the operation. Pre-and postoperative bacteriological and mycological screening is routinely performed, and the diagnosed infections are treated electively (Freeman, 1974) . Since this policy was adopted there has been a continuous reduction in the incidence of infeotive endocarditis.
The most important factor in the evaluation of tissue grafts for heart valve replacement is the evideace of satisfactory graft function over extended periods of time.
It has been shown that preserved homologous aortic valves in the aortic position are associated with a significant incidence of aortic regurgitation. The reported incidence of aortic regurgitation after homograft replacement varies from 37-8 % to 60 % Gonzalez-Lavin and Ross, 1970; Beach and Malm, 1972; Trimble, 1972) . A comparison of the incidence of regurgitant murmurs in aortic homografts with that encountered in the present series of fascial and pericardial grafts (11 6 %) is difficult because no really comparable data are available.
All the aortic diastolic murmurs in our series have appeared in the first eight months after surgery. Only two patients out of 40 with heterologous pericardial grafts have trivial aor,tic diastolic murmurs. The follow-up of this group of patients with pericardial grafts extends from 6 to 30 months, and 30 patients have a follow-up longer than 10 months.
In the mitral position there have been six instances of graft failure. In these patients the clinical deterioration was progressive but slow and the reoperation was performed as a scheduled procedure. In each of these six cases there was retraction and severe thickening of one cusp and slight to moderate thickening of the other two cusps of the autologous fascia lata valves. The fact that no relationship could be established between the circumferential position of the retracted cusp and the left ventricular outlet differs from the observations of MoEnany, Ross, and Yates (1972) and Ross (1972) . This finding supports the view that the flow pattern in the left ventricular outlet cannot be entirely responsible for valve graft failure.
Another observation was the fact that the degree of pathological changes was similar in all six failed grafts although the time of their removal varied widely from 10 to 38 months postoperatively.
Mitral systolic murmurs developed in 33 patients. None of them is presently in need of further surgical treatment. In 32 patients the murmur appeared during the first 12 postoperative months. In the majority of cases, the murmur has not increased in intensity and the clinical condition of the patients is good.
Although the number of patients with heterologous pericardial grafts in the mitral position is small and although the follow-up does not exceed 30 months, the absence of regurgitant murmurs in these cases is encouraging.
From the present series it became apparent that the same type of autologous fascial graft which has failed in six instances in the mitral position continues to function well in the aortic position up to four and a half years after implantation. It seems conceivable that biological factors alone cannot explain the failure phenomenon and that mechanical factors in valve graft construction and haemodynamic differences between the mitral and the aortic areas are equally if not principally responsible.
The long-term function of stented grafts in the tricuspid position cannot be assessed because of the very small number of patients (three with autologous and one with homologous fascia lata and three with heterologous pericardial valves) and owing to the differing periods of follow-up of these seven patients.
In order to understand the complex mechanism of function of frame-mounted tissue valves and in order to elucidate the causes of their different behaviour in the mitral as compared to the aortic position, hydrodynamic studies have been conducted in vitro using different valve testing machines.
The closing mechanism of three-cusp valves has been studied extensively (Bellhouse and Bellhouse, 1968) . On the other hand, the opening mechanism of these valves, especially in the mitral position, has not received enough attention.
Using a steady-state flow rig and several pulse simulators, we have studied a large number of frame-mounted, three-cusp tissue valves (Swales et al., 1973) . The conclusions of these investigations can be summarized as follows:
1. In virtually all valves examined the cusps opened in a sequential manner and the order in which the cusps of a particular valve opened was maintained irrespective of the circumferential position of the cusps as regards the left ventricular outlet in the testing apparatus.
2. Under the conditions prevailing in the experiment the sequential opening of the cusps seemed to be inherent to the design of the valve. Irregularities in the size and shape of the cusps or in the physical properties of the material accentuated this phenomenon.
3. Fully open valves were geometrically similar and the relationship between pressure gradient, flow rate, and valve diameter has the form: pd4=4600 Q2. This formula will apply to all such valves tested in water irrespective of material or size, provided that they are fully open.
4. The pressure gradient across the valve increases rapidly as the diameter of the valve is reduced, and with reduction in valve diameter complete valve opening can be achieved by a smaller flow rate. 6. In order to avoid sequential opening, the three cusps of the valve must be absolutely identical in thickness, pliability, and shape.
7. The construction of a perfect frame-mounted, three-cusp tissue valve is a real technical challenge.
8. All the factors mentioned above are less important for aortic valve grafts because in the aortic area complete opening of every cusp of the valve is facilitated by the forceful left ventricular ejection.
The average aortic peak blood flow velocity as well as the force applied to the aortic valve to open are higher than in the mitral area. The maximum ejection time of blood in the aortic root is considerably shorter than the period of rapid inflow from the left atrium through the mitral valve. The size of an aortic valve graft is always smaller than the size of a mitral valve. For the same cardiac output, considering that structurally and geometrically both valves are the same, the aortic valve has to open more fully.
With increasing knowledge about the function of fascial and pericardial grafts, a series of modifications and improvement in design, material, and construction have been made over the years.
Data concerning the use of fascia in general surgery show that, after autologous heterotopic transplantation outside the cardiovascular system, fascia continues to survive, maintaining its structure and function unchanged even after long periods of time. The use of autologous fascia as a heart valve replacement seems to follow a different pattern. The viability of the transplanted fibroblasts is uncertain (Lincoln et al., 1971) , and there is evidence that the stained nuclei visible on the surface and between the collagenous fibres of fascial grafts removed from the heart are invading, potentially active host cells (Silver and Trimble, 1972) . In these circumstances attempts to maintain the viability of the graft become unnecessary.
The construction of the graft in the operating theatre during surgery, with a limited amount of time available, does not offer the best conditions for the preparation of a perfect valve.
For these two reasons, we have replaced the autologous fascia lata with homologous fascia. Preparation of the graft in the laboratory gives ample time to a skilled assistant to select the most suitable piece of tissue and to construct the valve meticulously and unhurriedly. It can be inspected, tested, and then retained for clinical use only if it fulfils the criteria mentioned.
Preserved heterologous pericardium was used later instead of fascia lata because it was considered that the thinness and pliability of the pericardium are more important qualities for good valve functioning than the greater tensile strength of fascia lata. For sterilization and preservation of the valves made of heterologous pericardium we have used the method advocated by Carpentier and Dubost (1972) . It seems to prevent immunological reactions by reducing the antigenic potential of the tissue, and it prevents denaturation of the collagen by creating permanent intermolecular crosslinkages. In these circumstances the durability of the valve graft does not depend upon regeneration by host cells of the tissue used but rather on the stability of the biological material.
One specimen of heterologous pericardium examined six months after insertion in the aortic position and another one examined 12 months after insertion in the right ventricular outlet have shown that the structure of the pericardium was preserved intact and that host cell ingrowth did not take place. Macroscopically and microscopically both these grafts were identical with valve grafts before clinical implantation.
Several changes in graft construction have evolved from the clinical and experimental experience. For the small-size aortic valves (16 to 20 mm diameter) the prongs of the supporting frame have been splayed, and thereby the outflow or secondary orifice of the graft has been increased to equal the inflow opening at the base of the frame.
In order to prevent the unpredictable change in valve cusp shape during surgical insertion, the suturing rim is attached to the support frame only after the tissue graft has been stitched to the frame. Changes in position of the suturing rim can no longer distort the geometry of the graft. All these technical improvements have contributed to an improvement in clinical results.
CONCLUSIONS
The results obtained over a period of four and a half years with the first 213 patients with framemounted fascia lata and pericardial valves have shown differences between the function of the grafts in the two main implantation positions, the mitral and the aortic areas.
The experience with patients with aortic valve replacement has demonstrated an acceptable hospital and late mortality rate and good valve function with no graft failure up to four and a half years postoperatively. In this series, the incidence of aortic regurgitation has been low when compared with that encountered after aortic homograft valve replacement. Valves made of preserved heterologous pericardium have shown the lowest incidence of aortic diastolic murmurs.
The clinical results in patients with mitral valve replacement have been good although six grafts had to be removed due to failure, and half the patients who left hospital have developed mitral systolic murmurs.
However, long-term survivors with aortic as well as mitral tissue valve replacement have obtained considerable symptomatic improvement.
The incidence of thromboembolism has been low although anticoagulants were not used.
In a small series of patients with tricuspid replacement the follow-up has shown very good valve function with no failure or dysfunction, no thromboembolic complications, and considerable clinical improvement (Table IX) .
It is considered that if the physical properties conferred on the heterologous pericardium by the chemical treatment described are maintained and if host tissue ingrowth does not occur, the pericardial grafts should continue to function adequately for extended periods of time as heart valve replacement. There are some clinical and labora- By means of improved techniques and materials for valve construction it is anticipated that postoperative valve regurgitation could be reduced and the long-term function of the grafts maintained. The construction of a perfect valve graft is crucial for its long-term function. The merits of this method of heart valve replacement will continue to be evaluated as the period of followup increases.
